CTLA-4

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

CTLA-4
Mar 28, 2025, 14:09 | Oncolibrary
Ocular Side Effects Of Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy that enhances the body’s immune response…
Feb 25, 2025, 08:19 | Blog
Celebrating 30 Years of CTLA-4 - AACR
AACR shared a post on X: "Celebrating 30 Years of CTLA-4: Cancer Immunology Research deputy…
Feb 19, 2025, 13:54 | Blog
Prashant Kumar: Privileged to present an incredible data on Novel Cancer Vaccine PerCVax
Prashant Kumar, Chief Scientific Officer at Datar Cancer Genetics and Adjunct Professor at Indian Institute of…
Jan 29, 2025, 07:24 | Science
Justin Stebbing: Botensilimab Plus Balstilimab in Patients With Relapsed/Refractory Metastatic Sarcomas
Justin Stebbing, Professor of Biomedical Sciences at Anglia Ruskin University (ARU), shared his recent article on…
Jan 25, 2025, 15:56 | Blog
No recurrences in MSS colorectal cancer with BOT/BAL neoadjuvant immunotherapy: NEST Trial updates from ASCOGI25
The NEST Trial, conducted by Agenus, was presented with latest updates at the ASCO GI…
Jan 25, 2025, 15:26 | Blog
Hung Trinh: The future of cancer treatment - combining radiotherapy with immunotherapy
Hung Trinh, CMC/MFG Consultant and Managing Director at Vertex Biopharm Consulting, shared an article by…
Nov 9, 2024, 12:04 | Insight
Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology
This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…
Oct 29, 2024, 21:00 | Positive
Steven O'Day: At the Forefront of Immunotherapy
Dr. Steven O'Day, an immunotherapy pioneer and medical oncologist, is the Chief Medical Officer at…
Oct 25, 2024, 16:34 | Insight
Three decades of pioneering in Immune Oncology - Agenus
Agenus Inc. is a biopharmaceutical company and a prominent leader in the field of immuno-oncology,…
Sep 2, 2024, 19:15 | Insight
Patrick Hwu: How does anti-CTLA-4 and anti-PD-1 combination work mechanistically?
Patrick Hwu shared a post on LinkedIn: “The combination of anti-CTLA-4 and anti-PD-1 antibodies is…
Aug 31, 2024, 00:14 | Insight
Evelyn Wong: The 11th Asia Pacific Gastroenterology Cancer Summit
Evelyn Wong, Medical Oncologist at National Cancer Centre Singapore, shared a post on LinkedIn: “Where would…
Dec 8, 2023, 12:47 | Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Nov 17, 2023, 13:59 | Insight
Revolutionizing Cancer Immunotherapy: Next-Gen CTLA-4 Targeting and Combination Therapies
Dive into the groundbreaking research published in "Oncology Immunology" (2023), where leading scientists Nils-Petter Rudqvist,…
All: 13 Posts: 1 - 100
Special Coverage